Alcohol-Resistant Oral Pharmaceutical Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sustained-release oral pharmaceutical forms are vulnerable to rapid release of active ingredients when alcohol is consumed, posing safety risks and failing to provide consistent pharmacological effects over a long period, especially for severe pain management.
Innovation Solution
Development of microgranules with a neutral support coated by a layer containing an active ingredient and a hydrophobic polymer coating with at least 20% talc as an inert filler, which prevents immediate release and ensures sustained release kinetics even in acidic-alcoholic media, allowing for single daily administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If a sustained-release oral pharmaceutical form is designed to provide long-term pharmacological effect, then the duration of action is improved, but the reliability deteriorates when alcohol is consumed concomitantly causing rapid release
Solution Approach 1:
The patent employs a composite coating system consisting of multiple layers with different functional properties. The outer layer contains pH-dependent polymers that respond to gastrointestinal conditions, while the inner layer provides alcohol resistance. This multi-layer composite structure allows the formulation to maintain sustained-release characteristics under normal conditions while resisting alcohol-induced dose dumping, thereby simultaneously achieving long duration of action and reliable release control.
Solution Approach 2:
The patent utilizes pH-dependent polymers that change their physical and chemical parameters in response to pH variations in the gastrointestinal tract. These polymers remain intact in acidic environments (resisting alcohol-induced release) but dissolve at higher pH levels (intestinal conditions), enabling controlled release. This parameter-based control mechanism ensures reliable sustained-release performance regardless of alcohol consumption while maintaining the intended duration of pharmacological effect.
2Reliability
If a neutral support is made insoluble in water or alcohol to prevent immediate discharge, then the resistance to alcohol is improved, but the manufacturing complexity increases
Solution Approach 1:
The patent divides the coating system into distinct functional layers: an outer pH-dependent layer and an inner alcohol-resistant layer. This segmentation allows each layer to perform its specific function independently - the outer layer provides pH-triggered release while the inner layer prevents alcohol-induced dose dumping. The modular layered structure simplifies manufacturing compared to developing a single complex insoluble support, as each layer can be applied and optimized separately using standard coating techniques.
3Manufacturing precision
If pH-dependent polymers are used to control release, then the sustained release kinetics are improved, but the adaptability deteriorates due to variations in human behavior and intake conditions
Solution Approach 1:
The patent introduces an intermediary alcohol-resistant inner layer between the active ingredient core and the pH-dependent outer layer. This intermediary layer acts as a buffer that prevents direct interaction between alcohol and the active ingredient, ensuring consistent release kinetics regardless of alcohol consumption. The pH-dependent outer layer then controls the timed release of the active ingredient based on gastrointestinal pH conditions, which are more consistent across individuals than behavioral factors. This two-layer intermediary system decouples the release control mechanism from individual variations in intake behavior while maintaining precise dissolution kinetics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microgranules effectively resist immediate discharge of the active ingredient due to alcohol consumption, maintaining a consistent therapeutic effect over time with minimal variation in release profiles across different ethanol concentrations, thus enhancing patient safety and comfort.
Implementation Method 1
a coating layer comprising a hydrophobic coating polymer chosen from non-water-soluble derivatives of cellulose
Data Source
AI summary
The invention relates to a novel oral pharmaceutical composition which is resistant to immediate discharge of the dose of active ingredient due to alcohol and which enables a single daily intake.